Ttbio Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Ttbio's earnings have been declining at an average annual rate of -27.8%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 9.9% per year. Ttbio's return on equity is 1.5%, and it has net margins of 1.5%.
Belangrijke informatie
-27.8%
Groei van de winst
-27.8%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 11.5% |
| Inkomstengroei | 9.9% |
| Rendement op eigen vermogen | 1.5% |
| Nettomarge | 1.5% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Here's Why Ttbio (GTSM:6493) Can Afford Some Debt
Apr 30
Should Ttbio Corp. (GTSM:6493) Be Part Of Your Dividend Portfolio?
Mar 31Will Ttbio's (GTSM:6493) Growth In ROCE Persist?
Feb 03
Ttbio (GTSM:6493) Is Growing Earnings But Are They A Good Guide?
Dec 22Ttbio Corp.'s (GTSM:6493) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 03Should Ttbio Corp. (GTSM:6493) Be Part Of Your Dividend Portfolio?
Nov 18Opbrengsten en kosten
Hoe Ttbio geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 284 | 4 | 53 | 26 |
| 31 Mar 24 | 301 | 5 | 54 | 26 |
| 31 Dec 23 | 318 | 7 | 54 | 25 |
| 30 Sep 23 | 357 | 16 | 54 | 27 |
| 30 Jun 23 | 396 | 26 | 55 | 28 |
| 31 Mar 23 | 407 | 33 | 54 | 29 |
| 31 Dec 22 | 419 | 40 | 53 | 31 |
| 30 Sep 22 | 390 | 33 | 53 | 30 |
| 30 Jun 22 | 361 | 26 | 52 | 29 |
| 31 Mar 22 | 333 | 19 | 52 | 28 |
| 31 Dec 21 | 306 | 12 | 52 | 26 |
| 30 Sep 21 | 264 | 7 | 49 | 24 |
| 30 Jun 21 | 223 | 2 | 47 | 22 |
| 31 Mar 21 | 201 | 24 | 47 | 21 |
| 31 Dec 20 | 179 | 46 | 47 | 20 |
| 30 Sep 20 | 202 | 54 | 50 | 21 |
| 30 Jun 20 | 225 | 63 | 52 | 21 |
| 31 Mar 20 | 246 | 51 | 53 | 21 |
| 31 Dec 19 | 267 | 38 | 53 | 20 |
| 30 Sep 19 | 265 | 42 | 54 | 20 |
| 30 Jun 19 | 264 | 46 | 55 | 19 |
| 31 Mar 19 | 268 | 45 | 56 | 20 |
| 31 Dec 18 | 272 | 44 | 57 | 20 |
| 30 Sep 18 | 268 | 42 | 56 | 20 |
| 30 Jun 18 | 264 | 41 | 54 | 20 |
| 31 Mar 18 | 247 | 34 | 52 | 20 |
| 31 Dec 17 | 230 | 27 | 49 | 19 |
| 30 Sep 17 | 207 | 18 | 47 | 19 |
| 30 Jun 17 | 183 | 8 | 45 | 19 |
| 31 Mar 17 | 171 | 7 | 44 | 18 |
| 31 Dec 16 | 160 | 6 | 43 | 18 |
| 30 Sep 16 | 156 | 2 | 40 | 19 |
| 30 Jun 16 | 151 | -2 | 38 | 19 |
| 31 Mar 16 | 150 | -6 | 36 | 21 |
| 31 Dec 15 | 148 | -10 | 33 | 22 |
| 30 Sep 15 | 137 | -24 | 34 | 23 |
| 30 Jun 15 | 126 | -37 | 34 | 24 |
| 31 Mar 15 | 110 | -51 | 34 | 23 |
| 31 Dec 14 | 93 | -65 | 34 | 22 |
| 30 Sep 14 | 91 | -60 | 34 | 21 |
| 30 Jun 14 | 89 | -55 | 33 | 20 |
| 31 Mar 14 | 84 | -52 | 36 | 21 |
| 31 Dec 13 | 79 | -50 | 40 | 22 |
Kwaliteitswinsten: 6493 has high quality earnings.
Groeiende winstmarge: 6493's current net profit margins (1.5%) are lower than last year (6.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 6493's earnings have declined by 27.8% per year over the past 5 years.
Versnelling van de groei: 6493's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 6493 had negative earnings growth (-83.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (3.5%).
Rendement op eigen vermogen
Hoge ROE: 6493's Return on Equity (1.5%) is considered low.